Tag: interim analysis governance

Integrating DSM Plans with the Statistical Analysis Plan

Posted on digi By digi

Integrating DSM Plans with the Statistical Analysis Plan Integrating DSM Plans with Statistical Analysis Plans in Clinical Trials Introduction: Why Integration Matters In clinical trials, interim analyses are governed by two critical documents: the Data and Safety Monitoring (DSM) plan and the Statistical Analysis Plan (SAP). While the DSM plan focuses on oversight, safety, and…

Read More “Integrating DSM Plans with the Statistical Analysis Plan” »

Interim Analysis and Trial Termination, Statistical Thresholds for Early Stopping

Defining Efficacy and Futility Criteria

Posted on digi By digi

Defining Efficacy and Futility Criteria How to Define Efficacy and Futility Criteria in Clinical Trials Introduction: Why Stopping Rules Matter Pre-specified stopping rules are critical safeguards in clinical trial design. They allow Data Monitoring Committees (DMCs) to recommend continuing, modifying, or terminating a study based on interim results. These rules rely on clearly defined efficacy…

Read More “Defining Efficacy and Futility Criteria” »

Interim Analysis and Trial Termination, Pre-Specified Stopping Rules

How DMCs Interact with Sponsors

Posted on digi By digi

How DMCs Interact with Sponsors Understanding How Data Monitoring Committees Interact with Sponsors Introduction: The Sponsor–DMC Relationship Data Monitoring Committees (DMCs), or Data and Safety Monitoring Boards (DSMBs), provide independent oversight of clinical trials. While their independence is paramount, DMCs must still interact with sponsors to exchange critical information and ensure that safety and efficacy…

Read More “How DMCs Interact with Sponsors” »

Data Monitoring Committees (DMC), Interim Analysis and Trial Termination